Early full donor myeloid chimerism after reduced-intensity stem cell transplantation using a combination of fludarabine and busulfan

Hematopoietic Stem Cell Transplant Unit, National Cancer Center Hospital, Tokyo, Japan. BACKGROUND AND OBJECTIVES: The aim of this study was to evaluate lineage-specific chimerism reconstitution after reduced-intensity allogeneic stem cell transplantation (RIST) using a combination of fludarabine (3...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Haematologica (Roma) 2001-10, Vol.86 (10), p.1071-1074
Hauptverfasser:	Niiya, H, Kanda, Y, Saito, T, Ohnishi, T, Kanai, S, Kawano, Y, Kamijo, K, Iizuka, A, Yakushijin, K, Ueda, K, Chizuka, A, Iijima, K, Ohnishi, M, Nakai, K, Makimoto, A, Tanosaki, R, Tobinai, K, Wakasugi, H, Takaue, Y, Mineishi, S
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Antineoplastic Combined Chemotherapy Protocols - administration & dosage Biological and medical sciences Bone marrow, stem cells transplantation. Graft versus host reaction Busulfan - administration & dosage Cell Lineage - drug effects Female Graft Survival Hematologic Neoplasms - mortality Hematologic Neoplasms - therapy Hematopoietic Stem Cell Transplantation - methods Humans Male Medical sciences Middle Aged Myeloid Cells - cytology Prospective Studies Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplantation Chimera Vidarabine - administration & dosage Vidarabine - analogs & derivatives
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!